Gabrielė Milkintaitė, Goda Milašiūtė, Vidas Pilvinis
Abstract
Septic shock, a life-threatening condition, is treated with corticosteroids (CS), but their effectiveness remains debated. While some studies show benefits in reducing mortality and vasopressor use time, others find no significant impact. Corticosteroids can stabilize hemodynamics, especially in patients with adrenal insufficiency or refractory shock, but side effects like hyperglycemia require monitoring. Current guidelines suggest using CS for patients unresponsive to fluid resuscitation and vasopressors. However, optimal dosing, timing, and tapering strategies need further research to improve outcomes.
Keyword(s): septic shock, intensive care, corticosteroid therapy.
DOI: 10.35988/sm-hs.2026.091
Full Text: PDF
